tiprankstipranks
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
DAWN
Day One Biopharmaceuticals
RESEARCH TOOLSreports

Day One Biopharmaceuticals (DAWN) Stock News & Sentiment

463 Followers
Day One Biopharma Earnings Call Highlights Ojemda Surge
Premium
Company Announcements
Day One Biopharma Earnings Call Highlights Ojemda Surge
1M ago
DAWN
Hold Rating on Day One Biopharmaceuticals as Servier’s $2.5 Billion Takeout Caps Upside at $21.50 Target
Premium
Ratings
Hold Rating on Day One Biopharmaceuticals as Servier’s $2.5 Billion Takeout Caps Upside at $21.50 Target
1M ago
DAWN
Servier to Acquire Day One Biopharmaceuticals in Merger
Premium
Company Announcements
Servier to Acquire Day One Biopharmaceuticals in Merger
1M ago
8K
DAWN
Day One Biopharmaceuticals: Ojemda Uptake, Strong 2026 Guidance, and Underappreciated Emi‑Le Catalyst Support Buy Rating
Premium
Ratings
Day One Biopharmaceuticals: Ojemda Uptake, Strong 2026 Guidance, and Underappreciated Emi‑Le Catalyst Support Buy Rating
1M ago
DAWN
Day One Highlights OJEMDA’s EMA Progress, Updates Strategy
Premium
Company Announcements
Day One Highlights OJEMDA’s EMA Progress, Updates Strategy
1M ago
8K
DAWN
Day One Biopharmaceuticals: Durable OJEMDA Launch, De‑Risked Revenue Outlook, and Clinical Catalysts Underpin Buy Rating and $17 Price Target
Premium
Ratings
Day One Biopharmaceuticals: Durable OJEMDA Launch, De‑Risked Revenue Outlook, and Clinical Catalysts Underpin Buy Rating and $17 Price Target
1M ago
DAWN
Buy Rating Backed by Strong Ojemda Outperformance, Reaffirmed 2026 Revenue Outlook, and Pipeline Clinical Catalysts
Premium
Ratings
Buy Rating Backed by Strong Ojemda Outperformance, Reaffirmed 2026 Revenue Outlook, and Pipeline Clinical Catalysts
1M ago
DAWN
More DAWN News >

DAWN News on the Web

JonesTrading Sticks to Its Hold Rating for Day One Biopharmaceuticals (DAWN)
TipRanks News
Neutral
GLAZER CAPITAL, LLC Acquires Significant Stake in Day One Biopharmaceuticals Inc
GuruFocus News
Bullish
Oracle, Nike upgraded: Wall Street’s top analyst calls
TipRanks News
Bearish
Day One downgraded to Neutral from Overweight at JPMorgan
TipRanks News
Bearish
Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
TipRanks News
Neutral
Day One Biopharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
TipRanks News
Neutral
DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier
Zacks
Bullish
Day One Biopharma Earnings Call Highlights Ojemda Surge
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DAWN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DAWN’s Media Buzz Sentiment?
1 articles about DAWN were published this week. In an average week, 1 articles are published.
    What is DAWN’s weekly average amount of articles?
    In an average week, 1 articles about DAWN are published.
      What is DAWN’s News Sentiment?
      50% of articles about DAWN were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        HUMHumana
        ORGOOrganogenesis Holdings
        UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
        Showing the stocks with the most bullish news sentiment over the past week